JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyagawa, T.
Right arrow Articles by Blasberg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyagawa, T.
Right arrow Articles by Blasberg, R.
Journal of Nuclear Medicine Vol. 44 No. 11 1845-1854
© 2003 by Society of Nuclear Medicine


Basic Science Investigations

Assessment of Treatment Response by Autoradiography with 14C-Aminocyclopentane Carboxylic Acid, 67Ga-DTPA, and 18F-FDG in a Herpes Simplex Virus Thymidine Kinase/Ganciclovir Brain Tumor Model

Tadashi Miyagawa, MD1,2, Takamitsu Oku, MD1,3, Toshio Sasajima, MD1,4, Rovathi Dasai, MS1, Bradley Beattie, BS1, Ronald Finn, PhD5, Juri Gelovani Tjuvajev, MD, PhD1 and Ronald Blasberg, MD1

1 Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York
2 Department of Neurosurgery, Chiba University Graduate School of Medicine, Chiba, Japan
3 Department of Neurosurgery, Miyazaki Medical College, Miyazaki, Japan
4 Neurosurgical Service, Akita University Hospital, Akita, Japan
5 Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York

Assessments of herpes simplex virus 1 thymidine kinase (HSV-tk)/ganciclovir (GCV) treatment response, early in the course of therapy, are important in the evaluation and clinical management of patients. This study addresses whether imaging amino acid transport, glucose utilization, and passive vascular permeability provides an early indication of treatment response and can predict long-term outcome. Methods: Fischer 344 rats with intracerebral HSV-tk transduced RG2TK+ xenografts were studied. GCV-treated (50 mg/kg twice daily) and saline-treated control animals were compared; triple-label quantitative autoradiography was performed 3 d after initiating treatment, and long-term survival was determined. Autoradiograms of 18F-FDG, 67Ga-diethylenetriaminepentaacetic acid (67Ga-DTPA), and 14C-aminocyclopentane carboxylic acid (14C-ACPC) were obtained; measurements of 14C-ACPC and 67Ga-DTPA plasma clearance (K1), 14C-ACPC transport ({partial}K1), relative glucose utililization (R), and normalized radioactivity (% dose/g) were obtained in tumor and brain tissues. Adjacent sections were stained to detect apoptotic cells, microvessels, and type L neutral amino acid transporter in tumor and normal brain. Results: GCV treatment reduced {partial}K1 and % dose/g of 14C-ACPC in RG2TK+ xenografts to ~30% of that in nontreated animals (from 34 ± 9 [mean ± SD] to 9.5 ± 2.7 µL/min/g and from 0.28 ± 0.09 to 0.11 ± 0.04 % dose/g, respectively). GCV had a significant but substantially smaller effect than toxicity on glucose utilization and little or no effect on passive vascular permeability of RG2TK+ xenografts. These differences could not be explained by differences in plasma amino acid or glucose concentration at the time of the study. Histology revealed a large fraction of dead tumor cells and only a sparse distribution of apoptotic cells in GCV-treated tumors. Many CD34-positive endothelial cells in GCV-treated tumors showed only weak or marginal LAT1 staining, whereas CD98 staining remained unchanged. Survival was significantly increased by GCV treatment from 18 ± 4 to 56 ± 17 d. Conclusion: 14C-ACPC influx, K1ACPC, facilitated transport, {partial}K1ACPC, and % dose/g ACPC are good indicators of early treatment response after HSV-tk/GCV gene therapy. The parametric images and changes in K1ACPC, {partial}K1ACPC, and % dose/g ACPC are substantial and are better than the corresponding measures obtained in the same animals and in the same tissue (tumor) regions with 67Ga-DTPA and 18F-FDG. Amino acid transport imaging may be a good surrogate paradigm to monitor treatment response of brain tumors.

Key Words: herpes simplex virus 1/ganciclovir • aminocyclopentane carboxylic acid • DTPA • FDG • autoradiography




This article has been cited by other articles:


Home page
JNMHome page
H.-E. Wang, H.-M. Yu, R.-S. Liu, M. Lin, J. G. Gelovani, J.-J. Hwang, H.-J. Wei, and W.-P. Deng
Molecular Imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for Monitoring Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Prodrug Activation Gene Therapy of Cancer
J. Nucl. Med., July 1, 2006; 47(7): 1161 - 1171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.